Note: Ingredients listed on restricted chemical lists
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
N/A
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
N/A
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
238-877-9/14807-96-6
Name of the chemical
Talc
Concentration
N/A
General Information
Revision date
2022-04-20
Product name
TAFENOQUINE DISPERSIBLE 50MG TABLET
Product Synonyms
TAFENOQUINE DISPERSIBLE FILM COATED TABLET * TAFENOQUINE SUCCINATE, FORMULATED PRODUCT
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H372, H400, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
EU Classification
Regulation 26/12/2008-27092 as amended Classification in accordance with Regulation 28848 regarding the Classification, Packaging and Labeling of Substances and Preparations 12/11/2013.
2.1 Classification of the substance or mixture
Xn;R21/22-48/22, N;R51/53
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4 Specific target organ toxicity following Category 1 repeated exposure
Environmental hazards
Hazardous to the aquatic environment, acute Category 1 Hazardous to the aquatic environment, Category 1
2.2 Label elements
Labeling in accordance with Regulation 28848 regarding the Classification, Packaging and Labeling of Substances and Preparations 11/12/2013
Contains
HYDROXYPROPYL CELLULOSE, MICROCRYSTALLINE CELLULOSE, TAFENOQUINE, TALC, NON-ASBESTOS FORM, Titanium dioxide TAFENOQUINE. May produce an allergic reaction
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H372 Causes damage to organs through prolonged or repeated exposure. H400 Very toxic to aquatic life. H410 Very toxic to aquatic life with long lasting effects.
Prevention
P260 Do not breathe dust. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment.
Response
P330 Rinse mouth. P301 + P312 IF SWALLOWED: Immediately call the NATIONAL TOXICITY INFORMATION CENTRE AT 114 or a doctor/physician if you feel unwell. P310 Immediately call the NATIONAL TOXICITY INFORMATION CENTRE at 114 or a doctor/physician. P391 Collect spillage.
Storage
Store away from incompatible materials.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Additional information
76,664 % of the mixture consists of component(s) of unknown acute oral toxicity. 97,274 % of the mixture consists of component(s) of unknown acute dermal toxicity. 97,274 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 77,874 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 77,874 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. EUH208 -
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
